BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16361417)

  • 1. CCAAT/enhancer-binding protein beta represses human papillomavirus 11 upstream regulatory region expression through a promoter-proximal YY1-binding site.
    Ralph WM; Liu K; Auborn KJ
    J Gen Virol; 2006 Jan; 87(Pt 1):51-59. PubMed ID: 16361417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of C/EBPbeta represses human papillomavirus type 18 upstream regulatory region activity in HeLa cells by interfering with the binding of TATA-binding protein.
    Bauknecht T; Shi Y
    J Virol; 1998 Mar; 72(3):2113-24. PubMed ID: 9499067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diindolylmethane alters gene expression in human keratinocytes in vitro.
    Carter TH; Liu K; Ralph W; Chen D; Qi M; Fan S; Yuan F; Rosen EM; Auborn KJ
    J Nutr; 2002 Nov; 132(11):3314-24. PubMed ID: 12421845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A switch region determines the cell type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoter.
    Bauknecht T; Jundt F; Herr I; Oehler T; Delius H; Shi Y; Angel P; Zur Hausen H
    J Virol; 1995 Jan; 69(1):1-12. PubMed ID: 7983700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yin yang 1 negatively regulates the differentiation-specific E1 promoter of human papillomavirus type 6.
    Ai W; Narahari J; Roman A
    J Virol; 2000 Jun; 74(11):5198-205. PubMed ID: 10799595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel C/EBP beta-YY1 complex controls the cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region.
    Bauknecht T; See RH; Shi Y
    J Virol; 1996 Nov; 70(11):7695-705. PubMed ID: 8892890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C/EBPbeta is a negative regulator of human papillomavirus type 11 in keratinocytes.
    Wang H; Liu K; Yuan F; Berdichevsky L; Taichman LB; Auborn K
    J Virol; 1996 Jul; 70(7):4839-44. PubMed ID: 8676519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional control of human papillomavirus type 18 oncogene expression in different cell lines: role of transcription factor YY1.
    Jundt F; Herr I; Angel P; Zur Hausen H; Bauknecht T
    Virus Genes; 1995; 11(1):53-8. PubMed ID: 8808335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylated C/EBPβ influences a complex network involving YY1 and USF2 in lung epithelial cells.
    Viart V; Varilh J; Lopez E; René C; Claustres M; Taulan-Cadars M
    PLoS One; 2013; 8(4):e60211. PubMed ID: 23560079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5' region of the human papillomavirus type 31 upstream regulatory region acts as an enhancer which augments viral early expression through the action of YY1.
    Kanaya T; Kyo S; Laimins LA
    Virology; 1997 Oct; 237(1):159-69. PubMed ID: 9344918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an HPV33 natural variant with enhanced transcriptional activity suggests a role for C/EBPβ in the regulation of the viral early promoter.
    Alvarez J; Gagnon D; Coutlée F; Archambault J
    Sci Rep; 2019 Mar; 9(1):5113. PubMed ID: 30911096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular factor YY1 downregulates the human papillomavirus 16 E6/E7 promoter, P97, in vivo and in vitro from a negative element overlapping the transcription-initiation site.
    Lace MJ; Yamakawa Y; Ushikai M; Anson JR; Haugen TH; Turek LP
    J Gen Virol; 2009 Oct; 90(Pt 10):2402-2412. PubMed ID: 19553391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlapping YY1- and aberrant SP1-binding sites proximal to the early promoter of human papillomavirus type 16.
    Dong XP; Pfister H
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():2097-2101. PubMed ID: 10466808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of integrated human papillomavirus type 18 oncogene transcription in cells expressing SerpinB2.
    Darnell GA; Antalis TM; Rose BR; Suhrbier A
    J Virol; 2005 Apr; 79(7):4246-56. PubMed ID: 15767426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells.
    Chen KG; Sale S; Tan T; Ermoian RP; Sikic BI
    Mol Pharmacol; 2004 Apr; 65(4):906-16. PubMed ID: 15044620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
    Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
    J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [YY1 and its repressive effect on human papillomavirus 16 early promoter P97 existed widely among human epithelial cell lines].
    Dong X; Liu H; Pfister H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Sep; 12(3):217-22. PubMed ID: 12526319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel YY1-independent silencer represses the activity of the human papillomavirus type 16 enhancer.
    O'Connor MJ; Stünkel W; Zimmermann H; Koh CH; Bernard HU
    J Virol; 1998 Dec; 72(12):10083-92. PubMed ID: 9811748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers.
    Dong XP; Stubenrauch F; Beyer-Finkler E; Pfister H
    Int J Cancer; 1994 Sep; 58(6):803-8. PubMed ID: 7927871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCAAT/enhancer binding protein beta binds to and activates the P670 promoter of human papillomavirus type 16.
    Kukimoto I; Takeuchi T; Kanda T
    Virology; 2006 Mar; 346(1):98-107. PubMed ID: 16307770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.